Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022

SELL
$2.0 - $4.9 $29,402 - $72,034
-14,701 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$4.65 - $7.23 $68,359 - $106,288
14,701 New
14,701 $68,000
Q1 2021

May 17, 2021

SELL
$7.03 - $16.51 $95,875 - $225,163
-13,638 Closed
0 $0
Q4 2020

Feb 08, 2021

BUY
$5.76 - $11.95 $78,554 - $162,974
13,638 New
13,638 $93,000

Others Institutions Holding SRNE

About Sorrento Therapeutics, Inc.


  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Fox Run Management, L.L.C. Portfolio

Follow Fox Run Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Fox Run Management, L.L.C. with notifications on news.